Titlebook: Ethics and Drug Resistance: Collective Responsibility for Global Public Health; Euzebiusz Jamrozik,Michael Selgelid Book‘‘‘‘‘‘‘‘ 2020 The

Rotator-Cuff

A Capability Perspective on Antibiotic Resistance, Inequality, and Child Developmentties) requires that inequalities both in access to antibiotics and in risk factors for the dissemination and transmission of antibiotic resistance are addressed. Inequality undermines the cooperative activity that is control of infectious diseases and compounds the threat to the securing of capabili

Inferior

Fairness in the Use of Information About Carriers of Resistant Infectionsation use, resource plans for those needing services, and assurances of reciprocal support. Fairness in information use recognizes the ineluctable twinning of victims and vectors in the face of serious pandemic disease.

paleolithic

Antimicrobial Resistance and Social Inequalities in Health: Considerations of Justiceent to equality (I argue here) places in question the claimed normative superiority of priority and sufficiency. Using examples of the role of antimicrobials in both these trends?– and the future role of AMR?– I clarify (first) the multiple forms and dimensions of justice at play in health, and (sec

Uncultured

內(nèi)疚

affect

hematuria

hankering

,“What Are Filmmakers for in Needy Times?”,ponential growth of the population using antiretrovirals without careful monitoring increases the risk of significant antiretroviral drug resistance. In this chapter, I consider the example of single-drug interventions to prevent parent-to-child HIV transmission, and how the implementation of that s

FAZE

Mohammad Reza Zali,Atieh Sadat Chaychianopulations, and mandatory screening of possibly infected individuals prior to entering an area free of artemisinin-resistant malaria. We discuss ethical issues such as tensions between the wishes of individuals versus the broader goal of malaria elimination, and the risks of harm to interventional p

lymphedema

https://doi.org/10.1057/9780230373495cerbated by person-to-person transmission of multi-drug resistant organisms (MDRO), which have, so far, largely resisted the introduction of antimicrobial stewardship (AMS) programs and repeated campaigns to improve infection prevention and control (IPC). Despite clear evidence of efficacy in resear